Methyl-PEG4-NHS Ester TCI M2186

TCI M2186 622405-78-1 Methyl-PEG4-NHS Ester is a chemical compound widely used in biochemical and biomedical applications. This reagent is part of the PEGylation category, which involves the covalent attachment of polyethylene glycol (PEG) to biomolecules. In laboratory settings, it serves as a versatile tool for modifying proteins, lipids, and other molecules to enhance their stability, solubility, and biocompatibility. Its unique structure enables it to be a key component in various research and development processes.

The compound's reactive NHS (N-hydroxysuccinimide) group allows for efficient and selective conjugation with amino groups on proteins or other biomolecules. This reactivity ensures high specificity and minimal side reactions, making it a preferred choice for researchers aiming for precise molecular modifications. The molecule’s ability to form stable conjugates without compromising the integrity of the target molecule is a major advantage in both academic and industrial research environments.

In Indonesian laboratories, TCI M2186 622405-78-1 Methyl-PEG4-NHS Ester is commonly used in biomedical, pharmacological, and biotechnological research. Researchers rely on this compound for drug development, protein modification, and targeted therapy studies. Its availability in the local market supports the continuous progress of scientific research and innovation in the region.

• Biomedical Research – This compound is ideal for modifying biomolecules to enhance their stability and solubility in complex biological systems.
• Drug Development – It is used to conjugate therapeutic agents to proteins, improving their pharmacokinetic properties and targeting efficiency.
• Protein Modification – The NHS group enables efficient coupling with amino groups on proteins, facilitating the creation of functionalized biomolecules.
• Biotransformation Studies – Its reactivity supports the study of molecular interactions and conjugation processes in biological environments.
• Targeted Therapy Development – It allows for the precise attachment of therapeutic agents to specific molecular targets, enhancing treatment efficacy.

This compound should be stored at controlled room temperature, away from moisture and direct light to maintain its chemical integrity. It is recommended to use airtight containers to prevent exposure to humidity, which could affect its reactivity. In laboratory settings, it should be handled with appropriate personal protective equipment, such as gloves and safety goggles, to ensure safe handling. Due to its reactive nature, it should be stored separately from incompatible substances to avoid unintended chemical reactions. Proper labeling of storage containers is essential for safe access and use. Always follow standard laboratory safety protocols when working with this compound.

—